Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An announcement from Centerra Gold ( (TSE:CG) ) is now available.
On March 23, 2026, Centerra Gold Inc. reported that it had filed its 2025 annual report on Form 40-F with the U.S. Securities and Exchange Commission, including its annual information form, audited financial statements and management’s discussion and analysis. The same documents were filed with Canadian securities regulators and made accessible via EDGAR, SEDAR+ and the company’s website, underscoring Centerra’s continued regulatory compliance and transparency for investors in both markets, with hard copies of the financial statements available to shareholders on request.
The most recent analyst rating on (TSE:CG) stock is a Hold with a C$23.50 price target. To see the full list of analyst forecasts on Centerra Gold stock, see the TSE:CG Stock Forecast page.
Spark’s Take on CG Stock
According to Spark, TipRanks’ AI Analyst, CG is a Neutral.
The score is driven primarily by a strong, low-leverage balance sheet and attractive valuation (low P/E), partially offset by weak technical momentum and uneven cash-flow consistency.
To see Spark’s full report on CG stock, click here.
More about Centerra Gold
Centerra Gold Inc. is a Canadian-based gold mining company focused on operating, developing, exploring and acquiring gold and copper properties in North America, Türkiye and other global markets. It operates the Mount Milligan Mine in British Columbia and the Öksüt Mine in Türkiye, and also holds the Kemess Project in British Columbia, the Goldfield Project in Nevada, and a Molybdenum Business Unit in the United States and Canada, with shares listed on the TSX and NYSE.
YTD Price Performance: 10.12%
Average Trading Volume: 1,110,646
Technical Sentiment Signal: Buy
Current Market Cap: C$4.34B
Learn more about CG stock on TipRanks’ Stock Analysis page.

